Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (388)	8/11/2001 4:14:49 PM
From: tuck	Read Replies (1) \| Respond to of 668

Icebrg, That was November for 9 bucks/share; from the 8-K: >>On November 16, 2000, we issued a press release announcing the signing of a private placement of 5.2 million shares of our common stock at a purchase price of $9.00 per share. The purchase price of shares to be sold in the private placement was determined after the close of trading on Monday, November 13, 2000 and reflects a 10 percent discount from the last trade price of $10.00 per share for our common stock on that day.<< Think he'll get that much before the registration expires? The FDA would have to do something positive for CRIS before then, IMO, unless some bolt from the blue news comes out. I don't think it'll happen, BWDIK. I have no position. Cheers, Tuck